Total Payments
$1,940
2022 Payments
$30.82
Companies
20
Transactions
64
Medicare Patients
4,497
Medicare Billing
$799,310
Payment Breakdown by Category
Food & Beverage$1,940 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,940 | 64 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $574.38 | 15 | $0 (2020) |
| Celgene Corporation | $291.28 | 14 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $246.35 | 2 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $237.92 | 4 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $140.63 | 4 | $0 (2020) |
| GENZYME CORPORATION | $112.57 | 2 | $0 (2018) |
| Pharmacyclics LLC, An AbbVie Company | $48.06 | 4 | $0 (2020) |
| Ipsen Biopharmaceuticals, Inc | $38.52 | 2 | $0 (2017) |
| Foundation Medicine, Inc. | $36.81 | 3 | $0 (2018) |
| Agios Pharmaceuticals, Inc. | $31.32 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $30.82 | 2 | Bausch Health US, LLC ($15.85) |
| 2020 | $285.22 | 8 | Merck Sharp & Dohme Corporation ($239.92) |
| 2019 | $791.05 | 23 | Merck Sharp & Dohme Corporation ($334.46) |
| 2018 | $444.24 | 17 | E.R. Squibb & Sons, L.L.C. ($124.99) |
| 2017 | $388.39 | 14 | Bayer HealthCare Pharmaceuticals Inc. ($125.00) |
All Payment Transactions
64 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/06/2022 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Obesity | ||||||
| 01/09/2022 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Neurology | ||||||
| 03/10/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $114.94 | General |
| Category: ONCOLOGY | ||||||
| 02/21/2020 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Oncology | ||||||
| 02/13/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $92.77 | General |
| Category: ONCOLOGY | ||||||
| 02/13/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $9.45 | General |
| Category: ONCOLOGY | ||||||
| 02/11/2020 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: Oncology | ||||||
| 01/24/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $9.82 | General |
| Category: ONCOLOGY | ||||||
| 01/17/2020 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $12.94 | General |
| 01/07/2020 | Verastem, Inc. | Copiktra (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Hematology and Oncology | ||||||
| 12/12/2019 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $12.53 | General |
| Category: Hematology/Oncology | ||||||
| 12/05/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $6.01 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2019 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: Anemia | ||||||
| 10/07/2019 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $108.99 | General |
| Category: Oncology | ||||||
| 10/04/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: ONCOLOGY | ||||||
| 09/10/2019 | JAZZ PHARMACEUTICALS INC. | VYXEOS (Drug) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: ONCOLOGY | ||||||
| 08/15/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $111.17 | General |
| Category: ONCOLOGY | ||||||
| 07/24/2019 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $8.62 | General |
| Category: Oncology | ||||||
| 06/21/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: ONCOLOGY | ||||||
| 06/11/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: ONCOLOGY | ||||||
| 06/06/2019 | Merck Sharp & Dohme Corporation | EMEND (Drug), KEYTRUDA, LYNPARZA | Food and Beverage | In-kind items and services | $11.59 | General |
| Category: ONCOLOGY | ||||||
| 06/03/2019 | Celgene Corporation | Abraxane (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Oncology | ||||||
| 05/24/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: ONCOLOGY | ||||||
| 05/21/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: ONCOLOGY | ||||||
| 05/15/2019 | Celgene Corporation | Abraxane (Drug) | Food and Beverage | In-kind items and services | $127.70 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,304 | 3,432 | $1.3M | $251,062 |
| 2022 | 18 | 1,167 | 3,199 | $1.1M | $217,474 |
| 2021 | 17 | 1,262 | 2,843 | $1.0M | $203,518 |
| 2020 | 15 | 764 | 1,495 | $625,245 | $127,256 |
Total Patients
4,497
Total Services
10,969
Medicare Billing
$799,310
Procedure Codes
68
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 109 | 338 | $245,726 | $47,008 | 19.1% |
| 77301 | High precision radiation therapy planning | Office | 2023 | 108 | 130 | $212,030 | $40,229 | 19.0% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2023 | 95 | 1,196 | $157,332 | $39,276 | 25.0% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Office | 2023 | 108 | 130 | $113,880 | $21,585 | 19.0% |
| 77263 | Complex radiation therapy planning | Office | 2023 | 114 | 135 | $87,615 | $16,380 | 18.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 103 | 103 | $60,152 | $16,268 | 27.0% |
| 77435 | Management of cranial lesion surgery using radiation over multiple sessions | Office | 2023 | 28 | 29 | $71,543 | $13,637 | 19.1% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2023 | 129 | 272 | $83,504 | $11,927 | 14.3% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 135 | 447 | $54,981 | $10,806 | 19.7% |
| 77470 | Special radiation treatment | Office | 2023 | 77 | 92 | $38,456 | $7,207 | 18.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 41 | 50 | $20,550 | $6,356 | 30.9% |
| 77295 | 3d radiation therapy planning | Office | 2023 | 32 | 34 | $29,784 | $5,673 | 19.0% |
| 77293 | Obtaining respiratory data needed to develop the optimal radiation treatment | Office | 2023 | 50 | 58 | $23,722 | $4,460 | 18.8% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Office | 2023 | 29 | 263 | $21,303 | $3,985 | 18.7% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Office | 2023 | 29 | 32 | $10,208 | $1,950 | 19.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 18 | $5,508 | $1,599 | 29.0% |
| 77332 | Design and construction of simple radiation treatment device | Office | 2023 | 80 | 85 | $11,560 | $1,483 | 12.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 20 | $4,363 | $1,232 | 28.2% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2022 | 108 | 355 | $258,085 | $49,876 | 19.3% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2022 | 80 | 922 | $119,513 | $30,889 | 25.8% |
| 77301 | High precision radiation therapy planning | Office | 2022 | 86 | 95 | $154,945 | $29,806 | 19.2% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Office | 2022 | 85 | 94 | $82,344 | $15,850 | 19.2% |
| 77263 | Complex radiation therapy planning | Office | 2022 | 113 | 121 | $78,529 | $14,706 | 18.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 93 | 93 | $54,312 | $14,541 | 26.8% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2022 | 110 | 215 | $53,765 | $9,630 | 17.9% |
About Dr. Michael May, MD
Dr. Michael May, MD is a Radiation Oncology healthcare provider based in Little Rock, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/24/2015. The National Provider Identifier (NPI) number assigned to this provider is 1184011470.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael May, MD has received a total of $1,940 in payments from pharmaceutical and medical device companies, with $30.82 received in 2022. These payments were reported across 64 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,940).
As a Medicare-enrolled provider, May has provided services to 4,497 Medicare beneficiaries, totaling 10,969 services with total Medicare billing of $799,310. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Ad
Practice Information
- Specialty Radiation Oncology
- Location Little Rock, AR
- Active Since 04/24/2015
- Last Updated 01/13/2021
- Taxonomy Code 2085R0001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1184011470
Products in Payments
- KEYTRUDA (Biological) $549.85
- Abraxane (Drug) $263.30
- OPDIVO (Biological) $246.35
- Xofigo (Drug) $128.72
- TAGRISSO (Drug) $128.12
- IMFINZI (Drug) $109.80
- LIBTAYO (Drug) $100.40
- Imbruvica (Drug) $48.06
- MOZOBIL (Drug) $38.61
- FOUNDATIONONE (Device) $36.81
- IDHIFA (Drug) $31.32
- Lonsurf (Drug) $27.65
- Somatuline Depot 120mg-.5ml (Drug) $22.72
- Copiktra (Drug) $17.86
- VOTRIENT (Drug) $16.12
- APLENZIN (Drug) $15.85
- Revlimid (Drug) $15.47
- CONTRAVE (Drug) $14.97
- LIBTAYO CEMIPLIMAB-RWLC INJECTION (Biological) $13.57
- MEKINIST (Drug) $12.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Radiation Oncology Doctors in Little Rock
Dr. Fen Xia, Md, Phd, MD, PHD
Radiation Oncology — Payments: $3,408
Radiation Oncology $3,408
Christopher Pope, Md, MD
Radiation Oncology — Payments: $2,284
Radiation Oncology $2,284
Mark Storey, Md, MD
Radiation Oncology — Payments: $2,172
Radiation Oncology $2,172
Matthew Hardee, M.d., Ph.d, M.D., PH.D
Radiation Oncology — Payments: $2,076
Radiation Oncology $2,076
Leslie Harrell, D.o., M.s, D.O., M.S
Radiation Oncology — Payments: $1,218
Radiation Oncology $1,218
Jonathan Pagan, M.d, M.D
Radiation Oncology — Payments: $1,058
Radiation Oncology $1,058